Shield Therapeutics drops as CFO exits and Medicaid concerns weigh
Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) fell 12% to 7.71p after the group reported…
proactiveinvestors.co.uk

No data available
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $14.1B $12.6B–$15.4B | — | $3.89 | — | ±14% | High9 |
FY2024 | $11.7B $11.7B–$11.7B | ▼ -17.0% | $3.38 | ▼ -13.2% | ±8% | High9 |
FY2025 | $13.9B $13.9B–$13.9B | ▲ +18.8% | $4.39 | ▲ +29.8% | ±10% | High9 |
Dividend per payment — last 8 periods
Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) fell 12% to 7.71p after the group reported…

No company information available